We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATX icon
1226
Perspective Therapeutics
CATX
$338M
$123K ﹤0.01%
18,400
CGTX icon
1227
Cognition Therapeutics
CGTX
$101M
$121K ﹤0.01%
66,200
FIEE
1228
FiEE Inc
FIEE
$25.5M
$121K ﹤0.01%
+27,881
New +$104K
BLZE icon
1229
Backblaze
BLZE
$1.11B
$119K ﹤0.01%
27,500
ELTX icon
1230
Elicio Therapeutics
ELTX
$83.5M
$119K ﹤0.01%
12,500
-5,000
-29% -$45.9K
RVP icon
1231
Retractable Technologies
RVP
$20.2M
$118K ﹤0.01%
102,834
-66,700
-39% -$95.6K
XPL icon
1232
Solitario Resources
XPL
$68.1M
$118K ﹤0.01%
205,000
PRAX icon
1233
Praxis Precision Medicines
PRAX
$10.2B
$117K ﹤0.01%
6,780
-3,607
-35% -$55.2K
PRDS
1234
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$117K ﹤0.01%
64,600
-147,900
-70% -$270K
UPLD icon
1235
Upland Software
UPLD
$13.3M
$116K ﹤0.01%
+3,230
New +$111K
SURF
1236
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$115K ﹤0.01%
132,500
-75,000
-36% -$53.5K
MAMA icon
1237
Mama's Creations
MAMA
$860M
$115K ﹤0.01%
38,067
+15,625
+70% +$38.1K
UG icon
1238
United-Guardian
UG
$33.1M
$115K ﹤0.01%
13,466
CTHR
1239
DELISTED
Charles & Colvard Ltd
CTHR
$114K ﹤0.01%
11,889
HYPD
1240
Hyperion DeFi Inc
HYPD
$40.8M
$114K ﹤0.01%
599
HALL
1241
DELISTED
Hallmark Financial Services, Inc.
HALL
$113K ﹤0.01%
20,195
+310
+2% +$1.57K
ZDGE icon
1242
Zedge
ZDGE
$39.3M
$113K ﹤0.01%
50,480
DAVE icon
1243
Dave Inc
DAVE
$4.76B
$112K ﹤0.01%
21,000
ALIM
1244
DELISTED
Alimera Sciences
ALIM
$112K ﹤0.01%
38,300
+20,000
+109% +$45.9K
OCC icon
1245
Optical Cable Corp
OCC
$140M
$112K ﹤0.01%
27,600
NNVC icon
1246
NanoViricides
NNVC
$35.4M
$108K ﹤0.01%
94,039
RFL icon
1247
Rafael Holdings
RFL
$101M
$108K ﹤0.01%
52,379
XTNT icon
1248
Xtant Medical Holdings
XTNT
$60.3M
$106K ﹤0.01%
114,500
EDUC icon
1249
Educational Development Corp
EDUC
$11.8M
$106K ﹤0.01%
88,700
TSHA icon
1250
Taysha Gene Therapies
TSHA
$1.82B
$103K ﹤0.01%
156,300

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.